Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol Burst Suppression for Treatment-Resistant Depression
NCT02935647Phase 1Completed
- Sponsor
- University of Utah
- Start
- Oct 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of propofol in major depressive disorder (MDD), sponsored by University of Utah. Primary endpoint: Hamilton Rating Scale for Depression at 3 weeks. Started Oct 2016; status: completed.
02
Drugs
propofol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02935647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02935647.